Opportunity Information: Apply for CDC RFA GH20 2011

The Centers for Disease Control and Prevention (CDC), under the U.S. Department of Health and Human Services, announced a discretionary funding opportunity (CDC RFA GH20 2011) to strengthen laboratory diagnosis and monitoring in Caribbean countries supported by the President's Emergency Plan for AIDS Relief (PEPFAR). The purpose is to expand and sustain high quality laboratory services that directly affect HIV treatment outcomes and also bolster broader global health security. The award is structured as a cooperative agreement, which typically means the CDC expects to be actively involved with the recipient through ongoing technical collaboration and oversight rather than simply providing a grant with minimal engagement.

While the notice lists an award ceiling for Year 1 as "0" (meaning no fixed maximum cap is specified for the first year), the CDC indicates it anticipates approximately $1,000,000 in total funding for Year 1, contingent on the availability of funds. The opportunity is expected to result in a single award. Eligibility is described as unrestricted, meaning any type of entity may apply, although applicants would still need to meet any additional eligibility conditions described in the full notice. Applications were due by February 19, 2020 at 11:59 p.m. Eastern Time.

The core problem the opportunity is trying to address is that, even with prior progress, laboratory systems across the Caribbean still face gaps in efficiency, sustainability, and cost effectiveness. The CDC notes it has already provided targeted technical assistance and has helped achieve measurable gains, including the accreditation of six public health laboratories in the region. Even so, the NOFO argues that more support is needed to ensure laboratory networks can reliably deliver timely, quality assured diagnostic results at scale and over the long term, especially as countries work to expand HIV care and treatment programs and respond to other infectious disease threats.

Programmatically, the NOFO focuses on strengthening national and regional laboratory systems that support diagnostics and monitoring for HIV, tuberculosis (TB), sexually transmitted infections (STIs), and other emerging diseases of public health importance. The emphasis is not only on running individual tests, but on building the systems that make testing dependable and actionable: competent laboratory workforces, standardized and robust Quality Management Systems (QMS), and consistent quality assurance and quality control practices (QA/QC). A major element highlighted is implementation and continuation of the Strengthening Laboratory Management Toward Accreditation (SLMTA) program, a structured approach used globally to improve laboratory management and quality systems and to move labs toward recognized accreditation standards.

In practical terms, the CDC is looking for efforts that improve access to quality assured diagnostics, shorten turnaround times so clinicians and public health programs can act on results quickly, and optimize how testing networks are organized and run at the national level. That includes improving the performance and coordination of HIV and related testing networks so countries can provide reliable routine monitoring (such as tests used to track treatment response) while also improving their ability to detect and monitor outbreaks or emerging threats. By building stronger laboratory systems, the opportunity aims to support better patient care outcomes for HIV and related conditions and to strengthen disease surveillance capacity across the Caribbean, reinforcing preparedness and response as part of global health security.

  • The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Support for Laboratory Diagnosis and Monitoring to Scale Up and Improve HIV/AIDS Care and Treatment Services, and Strengthen Global Health Security for Caribbean Countries Supported under the President's Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
  • This funding opportunity was created on Dec 19, 2019.
  • Applicants must submit their applications by Feb 19, 2020 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The number of recipients for this funding is limited to 1 candidate(s).
  • Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
Apply for CDC RFA GH20 2011

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQ)

What is the name and reference number of this funding opportunity?

This is a discretionary funding opportunity from the Centers for Disease Control and Prevention (CDC) identified as CDC RFA GH20 2011.

Which federal agency is offering this opportunity?

The opportunity is offered by the Centers for Disease Control and Prevention (CDC), under the U.S. Department of Health and Human Services.

What is the main purpose of the award?

The purpose is to strengthen laboratory diagnosis and monitoring in Caribbean countries supported by the President's Emergency Plan for AIDS Relief (PEPFAR). The aim is to expand and sustain high-quality laboratory services that directly affect HIV treatment outcomes, while also strengthening broader global health security.

What type of funding mechanism is being used?

The award is structured as a cooperative agreement.

What does a cooperative agreement mean for the recipient?

A cooperative agreement typically means CDC expects to be actively involved with the recipient through ongoing technical collaboration and oversight, rather than providing funding with minimal engagement.

How much funding is expected for Year 1?

CDC indicates it anticipates approximately $1,000,000 in total funding for Year 1, contingent on the availability of funds.

Why does the notice list the Year 1 award ceiling as "0"?

The notice lists an award ceiling for Year 1 as "0" to indicate there is no fixed maximum cap specified for the first year, even though CDC anticipates about $1,000,000 in total Year 1 funding (subject to funds availability).

How many awards does CDC expect to make?

The opportunity is expected to result in a single award.

Who is eligible to apply?

Eligibility is described as unrestricted, meaning any type of entity may apply, as long as the applicant meets any additional eligibility conditions described in the full notice.

What geographic area is this opportunity focused on?

The focus is on Caribbean countries supported by PEPFAR.

What problem is this opportunity trying to solve?

The CDC notes that laboratory systems across the Caribbean still face gaps in efficiency, sustainability, and cost effectiveness. Despite prior progress and targeted technical assistance, additional support is needed to ensure laboratory networks can reliably deliver timely, quality-assured diagnostic results at scale and over the long term.

What progress has already been made in the region according to the notice?

The CDC reports it has provided targeted technical assistance and helped achieve measurable gains, including the accreditation of six public health laboratories in the region.

Which diseases and programs are included in the laboratory strengthening focus?

The NOFO focuses on strengthening national and regional laboratory systems that support diagnostics and monitoring for HIV, tuberculosis (TB), sexually transmitted infections (STIs), and other emerging diseases of public health importance.

Is the opportunity focused only on performing tests?

No. The emphasis is on building dependable laboratory systems that make testing reliable and actionable, including a competent laboratory workforce, standardized and robust Quality Management Systems (QMS), and consistent quality assurance and quality control (QA/QC).

What is SLMTA and how does it relate to this opportunity?

SLMTA stands for Strengthening Laboratory Management Toward Accreditation. The NOFO highlights implementation and continuation of SLMTA as a major element, describing it as a structured approach used globally to improve laboratory management and quality systems and move laboratories toward recognized accreditation standards.

What kinds of practical improvements is CDC looking for?

The NOFO emphasizes efforts that improve access to quality-assured diagnostics, shorten turnaround times so clinicians and public health programs can act on results more quickly, and optimize how national testing networks are organized and run.

How does this opportunity relate to HIV treatment outcomes?

By expanding and sustaining high-quality laboratory services and improving routine monitoring, the opportunity is intended to directly support HIV treatment outcomes, including timely and dependable diagnostic results that inform care and treatment decisions.

How does this opportunity support global health security?

Stronger laboratory systems and better coordinated testing networks improve the ability to detect and monitor outbreaks or emerging public health threats, strengthening disease surveillance capacity and preparedness and response across the Caribbean.

Does the NOFO mention improving turnaround time for results?

Yes. Shortening turnaround times is specifically mentioned so clinicians and public health programs can act on results quickly.

What laboratory system components are emphasized?

Key components include laboratory workforce competency, Quality Management Systems (QMS), and consistent quality assurance/quality control (QA/QC) practices, along with network performance and coordination.

What is the application deadline listed in the notice?

Applications were due by February 19, 2020 at 11:59 p.m. Eastern Time.

Is the Year 1 funding guaranteed?

No. The anticipated Year 1 total funding amount is contingent on the availability of funds.

Browse more opportunities from the same agency: Department of Health and Human Services, Centers for Disease Control - CGH

Browse more opportunities from the same category: Health

Next opportunity: Quantifying Religious Repression and Religious Conflict

Previous opportunity: Cooperative Ecosystem Studies Unit, Piedmont South Atlantic Coast CESU

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for CDC RFA GH20 2011

 

Applicants also applied for:

Applicants who have applied for this opportunity (CDC RFA GH20 2011) also looked into and applied for these:

Funding Opportunity
Strategic Use of Surveillance and Epidemiology to Support HIV Epidemic Control in Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2042

Funding Number: CDC RFA GH20 2042
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Scaling up and Improving Quality of Civil Registration and Vital Statistics in Malawi Through the National Registration Bureau under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2048

Funding Number: CDC RFA GH20 2048
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Maintaining and Strengthening Institutional Capacity of Cabo Delgado Province Health Directorate in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2054

Funding Number: CDC RFA GH20 2054
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Improving HIV Prevention, Care and Treatment Outcomes Among Faith Communities in Zambia by Implementing Critical Prevention Interventions for HIV Risk Reduction, Case Finding, and Linkage to Care and Treatment for Epidemic Control under PEPFAR Apply for CDC RFA GH20 2076

Funding Number: CDC RFA GH20 2076
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Human Resources for Health (HRH) to Achieve and Sustain HIV/TB Epidemic Control in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2053

Funding Number: CDC RFA GH20 2053
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Ryan White HIV/AIDS Program Part C Capacity Development Program Apply for HRSA 20 067

Funding Number: HRSA 20 067
Agency: Department of Health and Human Services, Health Resources and Services Administration
Category: Health
Funding Amount: $150,000
Eliminate Tuberculosis from Ethiopia Apply for 72066320RFA00001

Funding Number: 72066320RFA00001
Agency: Agency for International Development, Ethiopia USAID-Addis Ababa
Category: Health
Funding Amount: $38,000,000
Police and Prisons Activity Apply for 72062120RFA00003

Funding Number: 72062120RFA00003
Agency: Agency for International Development, Tanzania USAID-Dar es Salaam
Category: Health
Funding Amount: $19,800,000
Nurse Anesthetist Traineeships (NAT) Apply for HRSA 20 007

Funding Number: HRSA 20 007
Agency: Department of Health and Human Services, Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Prevention Epicenters Program: Protecting Patients from Infections, Antibiotic Resistance and Other Adverse Events Apply for RFA CK 20 004

Funding Number: RFA CK 20 004
Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: $600,000
Support and Capacity Building for Polio Eradication, Control of Other Vaccine Preventable Diseases, and Immunization Systems Strengthening in Africa. Apply for CDC RFA GH20 2001

Funding Number: CDC RFA GH20 2001
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
HQ Supported Development, Implementation, Use and Evaluation of Interoperable Health Information Systems to Achieve HIV/AIDS and TB Epidemic Control through Improved Health Informatics Policy, Governance, Workforce Capacity, and Systems under PEPFAR Apply for CDC RFA GH20 2036

Funding Number: CDC RFA GH20 2036
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Strengthening the Zambia Ministry of Health's Capacity to Provide Leadership to the National HIV/AIDS Response through Coordination, Policy Development, Mentorship and Training under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2072

Funding Number: CDC RFA GH20 2072
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Support HIV/AIDS Prevention, Care, and Treatment Activities for Mothers, Children, and Families under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2034

Funding Number: CDC RFA GH20 2034
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Comprehensive Approaches to Sustaining the Health System and HIV Response in the Republic of Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2058

Funding Number: CDC RFA GH20 2058
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Maintaining and Strengthening Institutional Capacity of Maputo Province Health Directorate in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2056

Funding Number: CDC RFA GH20 2056
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Health Promotion and Disease Prevention Research Centers: 2020 Special Interest Project Competitive Supplements (SIPS) Apply for RFA DP 20 003

Funding Number: RFA DP 20 003
Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: $4,500,000
Malaria Operations Research to Improve Malaria Control and Reduce Morbidity and Mortality in Western Kenya Apply for RFA GH 20 002

Funding Number: RFA GH 20 002
Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: $2,000,000
Enhancing Strategic Information Capacity for HIV/AIDS Programs towards Sustaining Epidemic Control in Kenya through Monitoring and Evaluation (M&E) and Data Science under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2043

Funding Number: CDC RFA GH20 2043
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Quality Facility and Community-Based HIV Prevention, Case Finding, Care and Treatment, and Viral Suppression to Reach Epidemic Control in Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2085

Funding Number: CDC RFA GH20 2085
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH20 2011", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: